메뉴 건너뛰기




Volumn 87, Issue 10, 2009, Pages 417-420

Topical tacrolimus (FK506) for the treatment of feline idiopathic facial dermatitis

Author keywords

Cats; Feline idiopathic facial dermatitis; Persian cat; Tacrolimus

Indexed keywords

ANTIFUNGAL AGENT; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

EID: 70349316762     PISSN: 00050423     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-0813.2009.00488.x     Document Type: Article
Times cited : (11)

References (9)
  • 2
    • 0346565519 scopus 로고
    • Hereditary primary seborrhea oleosa in Persian cats
    • Paradis M, Scott D. Hereditary primary seborrhea oleosa in Persian cats. Feline practice 1990 18 (1 17 20.
    • (1990) Feline Practice , vol.18 , Issue.1 , pp. 17-20
    • Paradis, M.1    Scott, D.2
  • 4
    • 0023245677 scopus 로고
    • FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics
    • Kino T, Hatanaka H, Hashimoto M et al. FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. J Antibiotics 1987 40 : 1249.
    • (1987) J Antibiotics , vol.40 , pp. 1249
    • Kino, T.1    Hatanaka, H.2    Hashimoto, M.3
  • 5
    • 0023261356 scopus 로고
    • FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro
    • Kino T, Hatanaka H, Miyata S et al. FK-506, a novel immunosuppressant isolated from a Streptomyces. II: Immunosuppressive effect of FK-506 in vitro. J Antibiotics 1987 40 : 1256 1265. (Pubitemid 17138110)
    • (1987) Journal of Antibiotics , vol.40 , Issue.9 , pp. 1256-1265
    • Kino, T.1    Hatanaka, H.2    Miyata, S.3
  • 6
    • 0026575932 scopus 로고
    • The mechanism of action of cyclosporin A and FK 506
    • Schreiber SL, Crabtree GR. The mechanism of action of cyclosporin A and FK 506. Immunol Today 1992 13 : 136 142.
    • (1992) Immunol Today , vol.13 , pp. 136-142
    • Schreiber, S.L.1    Crabtree, G.R.2
  • 7
    • 8744241360 scopus 로고    scopus 로고
    • Investigation on the clinical efficacy and safety of 0.1% tacrolimus ointment (Protopic®) in canine atopic dermatitis: A randomized, double-blinded, placebo-controlled, cross-over study
    • Marsella R, Nicklin CF, Saglio S, Lopez J. Investigation on the clinical efficacy and safety of 0.1% tacrolimus ointment (Protopic®) in canine atopic dermatitis: a randomized, double-blinded, placebo-controlled, cross-over study. Vet Dermatol 2004 15 : 294 303.
    • (2004) Vet Dermatol , vol.15 , pp. 294-303
    • Marsella, R.1    Nicklin, C.F.2    Saglio, S.3    Lopez, J.4
  • 8
    • 0000339161 scopus 로고    scopus 로고
    • In vitro measurement of canine and feline IgE: A review of FceR1a-based assays for detection of allergen-reactive IgE
    • Grieve RB, Wassom DL. In vitro measurement of canine and feline IgE: a review of FceR1a-based assays for detection of allergen-reactive IgE. Vet Dermatol 1998 9 : 173 178.
    • (1998) Vet Dermatol , vol.9 , pp. 173-178
    • Grieve, R.B.1    Wassom, D.L.2
  • 9
    • 77954632352 scopus 로고    scopus 로고
    • Tacrolimus (marketed as Protopic Ointment) Information. . Accessed July
    • Tacrolimus (marketed as Protopic Ointment) Information. US Food and Drug Administration. http://www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ucm107845.htm. Accessed July 2009.
    • (2009) US Food and Drug Administration


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.